Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa .

, phenotypically and genotypically. We have also shown that intensifying the regimen and using combination therapy are both strategies that can both treat HAP and suppress the emergence of resistance.